Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis.
about
Sepsis: in search of cure.Kukoamine B promotes TLR4-independent lipopolysaccharide uptake in murine hepatocytes.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.Recent developments in severe sepsis research: from bench to bedside and back.Targeting Toll-like receptor 4 prevents cobalt-mediated inflammation.Toll-like receptor genetic variations in bone marrow transplantation.Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment.Potential Mechanisms Underlying Inflammation-Enhanced Aminoglycoside-Induced Cochleotoxicity.Toll-Like Receptor 4 on both Myeloid Cells and Dendritic Cells Is Required for Systemic Inflammation and Organ Damage after Hemorrhagic Shock with Tissue Trauma in Mice.TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults.
P2860
Q30251753-5F660883-0381-423B-95D3-CF62EF8BF538Q37628894-3E41C9D9-309C-4A74-A953-6E80F13B6598Q38557048-718A5E9C-2F6C-4255-8A49-54777558592BQ38724278-39A4E39E-487B-47B3-A554-0A32E0046F75Q40028662-AD9D5C53-5E3A-49DA-98A3-882C3211B4B6Q40209654-E3093D93-DA49-41D7-AC3C-CA20CF3E1A83Q40608326-C172A629-0DDC-4900-88A5-22347C3B8619Q46895698-DF3624CD-0F6C-4AF7-9AEC-7DD9FB80687EQ47128203-475FA4C4-D285-491E-AC1A-C747C54BB1D5Q47140454-A0A245F9-DC04-427C-B007-9E930BEEE08BQ47142963-C9016AA6-D5A7-417D-850C-0B66F70C97F6Q48641496-8C7828B7-E427-4C98-A4CF-E4DB5E8155CFQ50324081-0E47BBF0-6248-4A73-847B-703C313BE238
P2860
Therapeutic Effects of Treatment with Anti-TLR2 and Anti-TLR4 Monoclonal Antibodies in Polymicrobial Sepsis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@ast
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@en
type
label
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@ast
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@en
prefLabel
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@ast
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@en
P2093
P2860
P1433
P1476
Therapeutic Effects of Treatme ...... odies in Polymicrobial Sepsis.
@en
P2093
Caio Tavares Fagundes
Cristiano Xavier Lima
Danielle Gloria Souza
Flavio Almeida Amaral
Greg Elson
Irla Paula Stopa Rodrigues
Jose Carlos Alves-Filho
Limin Shang
Marie Kosco-Vilbois
Mauro Martins Teixeira
P2860
P304
P356
10.1371/JOURNAL.PONE.0132336
P407
P577
2015-07-06T00:00:00Z